Obara W - Search Results

1

[Side effect and supportive care to combination of gemcitabine and cisplatin chemotherapy for the advanced urothelial cancer].

Kato Y, Sato J, Kato R, Takata R, Obara W. Kato Y, et al. Among authors: obara w. Nihon Rinsho. 2015 Feb;73 Suppl 2:609-13. Nihon Rinsho. 2015. PMID: 25831832 Japanese. No abstract available.

2

A Japanese registry study and systematic review of particle therapy for renal cell carcinoma.

Ishikawa H, Arimura T, Maruo K, Kawamura H, Toyama S, Ogino T, Okimoto T, Murakami M, Sato Y, Nishioka K, Araya M, Ohba H, Umehara K, Aoyama H, Obara W, Azuma H, Tsuji H, Sakurai H. Ishikawa H, et al. Among authors: obara w. J Radiat Res. 2023 Jun 16;64(Supplement_1):i41-i48. doi: 10.1093/jrr/rrad010. J Radiat Res. 2023. PMID: 37045797 Free PMC article.

3

Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database.

Araya M, Ishikawa H, Nishioka K, Maruo K, Asakura H, Iizumi T, Takagi M, Murakami M, Azuma H, Obara W, Aoyama H, Sakurai H. Araya M, et al. Among authors: obara w. J Radiat Res. 2023 Jun 16;64(Supplement_1):i49-i58. doi: 10.1093/jrr/rrad027. J Radiat Res. 2023. PMID: 37185773 Free PMC article.

4

Eight year experience with Studer ileal neobladder.

Obara W, Isurugi K, Kudo D, Takata R, Kato K, Kanehira M, Iwasaki K, Tanji S, Konda R, Fujioka T. Obara W, et al. Jpn J Clin Oncol. 2006 Jul;36(7):418-24. doi: 10.1093/jjco/hyl047. Epub 2006 Jun 27. Jpn J Clin Oncol. 2006. PMID: 16803843

5

Study of the prediction system for clinical response to M-VAC neoadjuvant chemotherapy for bladder cancer.

Takata R, Obara W, Fujioka T. Takata R, et al. Among authors: obara w. Aktuelle Urol. 2010 Jan;41 Suppl 1:S41-5. doi: 10.1055/s-0029-1224655. Epub 2010 Jan 21. Aktuelle Urol. 2010. PMID: 20094952

6

Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.

Obara W, Ohsawa R, Kanehira M, Takata R, Tsunoda T, Yoshida K, Takeda K, Katagiri T, Nakamura Y, Fujioka T. Obara W, et al. Jpn J Clin Oncol. 2012 Jul;42(7):591-600. doi: 10.1093/jjco/hys069. Epub 2012 May 25. Jpn J Clin Oncol. 2012. PMID: 22636067 Clinical Trial.

7

Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling.

Kato Y, Zembutsu H, Takata R, Miya F, Tsunoda T, Obara W, Fujioka T, Nakamura Y. Kato Y, et al. Among authors: obara w. Exp Ther Med. 2011 Jan;2(1):47-56. doi: 10.3892/etm.2010.166. Epub 2010 Nov 30. Exp Ther Med. 2011. PMID: 22977468 Free PMC article.

8

Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.

Iwasaki K, Obara W, Kato Y, Takata R, Tanji S, Fujioka T. Iwasaki K, et al. Among authors: obara w. Jpn J Clin Oncol. 2013 Feb;43(2):193-9. doi: 10.1093/jjco/hys213. Epub 2012 Dec 28. Jpn J Clin Oncol. 2013. PMID: 23275643

9

Concurrence of villous adenoma and non-muscle invasive bladder cancer arising in the bladder: a case report and review of the literature.

Kato Y, Konari S, Obara W, Sugai T, Fujioka T. Kato Y, et al. Among authors: obara w. BMC Urol. 2013 Jul 20;13:36. doi: 10.1186/1471-2490-13-36. BMC Urol. 2013. PMID: 23870731 Free PMC article. Review.

10

Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment.

Kato R, Obara W, Matsuura T, Kato Y, Iwasaki K, Fujioka T. Kato R, et al. Among authors: obara w. Jpn J Clin Oncol. 2014 May;44(5):479-85. doi: 10.1093/jjco/hyu018. Epub 2014 Mar 30. Jpn J Clin Oncol. 2014. PMID: 24688083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters